{"id":6781,"date":"2025-09-11T23:02:48","date_gmt":"2025-09-11T23:02:48","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/09\/11\/trump-chinese-biotech-crackdown-readout-loud-podcast\/"},"modified":"2025-09-11T23:02:48","modified_gmt":"2025-09-11T23:02:48","slug":"trump-chinese-biotech-crackdown-readout-loud-podcast","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/09\/11\/trump-chinese-biotech-crackdown-readout-loud-podcast\/","title":{"rendered":"Trump, Chinese biotech, and an industry career reshaped by illness"},"content":{"rendered":"<p>    Trump, Chinese biotech, and an industry career reshaped by illness<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>On this week\u2019s episode of \u201cThe Readout LOUD\u201d: a drug-industry career reshaped by illness, and the potential for political blowback against Chinese biotech.<\/p>\n<p>Listeners of this podcast probably know pharma consultant Mike Rea for his annual ranking of drug company R&amp;D productivity. But this week, he penned a poignant <a href=\"https:\/\/ideapharma.substack.com\/p\/its-not-you-its-me?r=cuyzj&amp;utm_medium=ios&amp;triedRedirect=true\">personal essay<\/a> explaining how some medical setbacks have impacted his professional life. He joins us to discuss.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/09\/11\/trump-chinese-biotech-crackdown-readout-loud-podcast\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Adam Feuerstein, Elaine Chen, and Allison DeAngelis<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/09\/11\/trump-chinese-biotech-crackdown-readout-loud-podcast\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Trump, Chinese biotech, and an industry career reshaped by illness On this week\u2019s episode of \u201cThe Readout LOUD\u201d: a drug-industry career reshaped by illness, and the potential for political blowback against Chinese biotech. Listeners of this podcast probably know pharma consultant Mike Rea for his annual ranking of drug company R&amp;D productivity. But this week, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2154,2562,2177,2155,2265],"tags":[2150],"class_list":["post-6781","post","type-post","status-publish","format-standard","hentry","category-biotechnology","category-china","category-donald-trump","category-pharmaceuticals","category-the-readout-loud","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6781"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=6781"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/6781\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=6781"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=6781"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=6781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}